
HD Labs Semaglutide/Ozempic 10mg
R 1 855,00 Regular Price
R 1 430,00Sale Price
Key Research Benefits
Robust Weight Loss: For example, in the STEP trials, weekly semaglutide at ~2.4 mg achieved mean weight losses from ~14.9% to ~17.4% at 68 weeks.
Improved Glucose & Insulin Response: Participants without diabetes saw reduced fasting glucose and improved insulin sensitivity.
Visceral Fat Reduction & Cardiometabolic Impact: Some long-term studies show sustained waist‐size decreases and improved cardiovascular risk markers.
Enhanced Satiety & Appetite Control: GLP-1 activation reduces hunger and slows gastric emptying, supporting weight-management research aims.